Combination vaccine for intradermal administration
WO2021026082A1
System and method for determning status of health of animals arriving at a feed location
WO2021013981A1
Crystalline form of telmapitant or (5r,8s)-8-[[(1r)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-8-phenyl-1,3,7-triazaspiro[4.5]decane-2,4-dione
WO2021013825A1
Soft chewable veterinary dosage form
WO2021009187A1
Caninized antibodies against canine ctla-4
WO2021009188A1
Caninized antibodies to human and canine ctla-4
WO2021001462A1
Conjugated deoxynivalenol to protect against mycotoxicosis
WO2020245355A1
Mdbk irf3/irf7 knock out mutant cell and its use for vaccine production
WO2020221914A1
Process for the production of ethyl 3-amino-1-[(3r,4s)-4-cyanotetrahydropyran-3-yl]pyrazole-4-carboxylate through chiral separation of a racemic mixture
WO2020225143A1
Injectable pharmaceutical compositions and uses thereof
WO2020201048A1
Stabilisation of live mollicutes bacteria in a liquid composition
WO2020127935A1
Method for producing (5s)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4hisoxazol-3-yl]-2-methyl-benzoic acid
AR115292A1
METHOD FOR RACEMIZATION OF (5R) -4- [5- (3,5-DICHLOROPHENYL) -5- (TRIFLUOROMETHYL) -4H-ISOXAZOL-3-IL] -2-METHYL-BENZOIC ACID
TW202039450A
Method for producing (5s)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4h-isoxazol-3-yl]-2-methyl-benzoic acid
WO2020127941A2
Serum free intracellular pathogen vaccine
WO2020127765A1
Crystalline phosphate salts
WO2020127735A1
New methods of producing (2-amino-4-[6-(4-fluorophenyl)-2-[(4-methyl-1-piperazinyl)methyl]imidazo[2,1-b]thiazol-5-yl]-pyrimidine
WO2020127730A1
Prime-boost vaccination regimen
WO2020120679A1
Crystalline forms of 1-[(3r,4s)-4-cyanotetrahydropyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridyl)amino]pyrazole-4-carboxamide
WO2020120673A1
Process for preparing 1-[(3r,4s)-4-cyanotetrahydropyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridyl)amino]p yrazole-4-carboxamide
